Cargando…
Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy()
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964506/ https://www.ncbi.nlm.nih.gov/pubmed/35370296 http://dx.doi.org/10.1016/j.curtheres.2022.100667 |
| _version_ | 1784678235064238080 |
|---|---|
| author | Yacyshyn, Mary Beth Collins, James Chua, Michelle Siegwald, Angela Yacyshyn, Sara Briones-Pryor, Valerie Yacyshyn, Bruce |
| author_facet | Yacyshyn, Mary Beth Collins, James Chua, Michelle Siegwald, Angela Yacyshyn, Sara Briones-Pryor, Valerie Yacyshyn, Bruce |
| author_sort | Yacyshyn, Mary Beth |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8964506 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-89645062022-03-30 Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() Yacyshyn, Mary Beth Collins, James Chua, Michelle Siegwald, Angela Yacyshyn, Sara Briones-Pryor, Valerie Yacyshyn, Bruce Curr Ther Res Clin Exp Letter to the Editor Elsevier 2022-03-30 /pmc/articles/PMC8964506/ /pubmed/35370296 http://dx.doi.org/10.1016/j.curtheres.2022.100667 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Letter to the Editor Yacyshyn, Mary Beth Collins, James Chua, Michelle Siegwald, Angela Yacyshyn, Sara Briones-Pryor, Valerie Yacyshyn, Bruce Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title | Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title_full | Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title_fullStr | Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title_full_unstemmed | Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title_short | Feasibility study of Bismuth Subsalicylate (BSS) as an addition to standard of care for COVID-19 therapy() |
| title_sort | feasibility study of bismuth subsalicylate (bss) as an addition to standard of care for covid-19 therapy() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964506/ https://www.ncbi.nlm.nih.gov/pubmed/35370296 http://dx.doi.org/10.1016/j.curtheres.2022.100667 |
| work_keys_str_mv | AT yacyshynmarybeth feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT collinsjames feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT chuamichelle feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT siegwaldangela feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT yacyshynsara feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT brionespryorvalerie feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy AT yacyshynbruce feasibilitystudyofbismuthsubsalicylatebssasanadditiontostandardofcareforcovid19therapy |